Roche breast cancer drug gets expanded US pre-surgery approval - Reuters

[INCIID News Feed]

Vancouver Sun
<img alt="" height="1" width="1" />
Roche breast cancer drug gets expanded US pre-surgery approval
Reuters
Mon Sep 30, 2013 12:18pm EDT. (Reuters) - U.S. health regulators expanded the approval of Roche Holding AG&#39;s breast cancer drug Perjeta and will now allow its use to help shrink tumors prior to surgery, the Food and Drug Administration said on Monday.
FDA approves Perjeta for neoadjuvant breast cancer treatmentFDA.gov
FDA approves first pre-surgical breast cancer drugNews & Observer
FDA panel says Roche drug works for new approach in treating breast cancer ...StarPhoenix
The Times (subscription)
all 9 news articles &raquo;


More...